ライフサイエンスコーパス: lactis

1 The construct was introduced into L lactis.

2 st in a culture of the bacterium Lactococcus lactis.

3 ng type a (MATa) to MATalpha in the yeast K. lactis.

4 lus bulgaricus, and Lactococcus lactis subsp Lactis.

5 the unicellular budding yeast Kluyveromyces lactis.

6 omodimeric multidrug ABC transporter from L. lactis.

7 n-specific S component BioY from Lactococcus lactis.

8 intranasally with Shr-expressing Lactococcus lactis.

9 udied Sir2 from another yeast, Kluyveromyces lactis.

10 derived from the budding yeast Kluyveromyces lactis.

11 d expressed this fusion protein (MBP*) in L. lactis.

12 e in the nonpathogenic bacterium Lactococcus lactis.

13 iotic) produced by Lactococcus lactis subsp. lactis.

14 teria, Enterococcus faecalis and Lactococcus lactis.

15 al gene as is still present in Kluyveromyces lactis.

16 ise unrelated plasmid pRS01 from Lactococcus lactis.

17 lation of glucose utilization in Lactococcus lactis.

18 fficiency conjugation process in Lactococcus lactis.

19 ar poles in Escherichia coli and Lactococcus lactis.

20 in this elongation in the yeast Kluveromyces lactis.

21 ined the ability to uptake (3)H-biotin by L. lactis.

22 genes present in the probiotic bacterium L. lactis.

23 resent study to separate copies of the six L.lactis 23S rRNA genes, within operon B or D.

24 .LtrB intron from Lactococcus lactis into L. lactis 23S rRNA.

25 iod (SCORAD-score pre-/post-intervention: B. lactis 25.9 [95% CI: 22.8-29.2] to 12.8 [9.4-16.6]; L. p

26 ically to the Class 1A DHOD from Lactococcus lactis, 3,4-dihydroxybenzoate (3,4-diOHB) and 3,5-dihydr

27 ate that, in the budding yeast Kluyveromyces lactis, a DNA rearrangement associated with mating type

28 amily of Siphoviridae and infect Lactococcus lactis, a gram-positive bacterium used in commercial dai

29 Lactococcus lactis, a non-pathogenic bacteria, has been genetically

30 In a relatively recent ancestor of K. lactis, a reorganization occurred.

31 us Sfp transferase required to modify the L. lactis AcpA and the chimera of L. lactis AcpA helix II i

32 pP helix II was due to incompatibility of L. lactis AcpA helix I with the downstream elements of AcpP

33 Expression of the AcpP protein L. lactis AcpA helix II allowed weak growth, whereas the L.

34 ify the L. lactis AcpA and the chimera of L. lactis AcpA helix II in AcpP).

35 Replacement of the L. lactis AcpA helix II residues in this protein showed tha

36 s showed that the lack of function of the L. lactis AcpA-derived protein containing E. coli AcpP heli

37 helix II allowed weak growth, whereas the L. lactis AcpA-derived protein that contained E. coli AcpP

38 homologous KLLA0A09713 gene of Kluyveromyces lactis allow for cross-complementation of the respective

39 roorotate dehydrogenases from E. coli and L. lactis also have a lysine near N5 of the flavin.

40 Expression of the recombinant protein in L. lactis also markedly increased biofilm formation.

41 ited by 50% CFS of Lactococcus lactis subsp. lactis and 25% CFS of Leuconostoc lactis. subsp. cremori

42 to divergent yeasts, including Kluyveromyces lactis and alternative S. cerevisiae strains.

43 tosidases (Bacillus circulans, Kluyveromyces lactis and Aspergillus oryzae) was analysed in detail, a

44 dases from Bacillus circulans, Kluyveromyces lactis and Aspergillus oryzae.

45 tions from Aspergillus oryzae, Kluyveromyces lactis and Bacillus circulans.

46 the phenotypic variation in resistance to L. lactis and E. faecalis, respectively, most of the molecu

47 However, the AcpAs of Lactococcus lactis and Enterococcus faecalis were inactive.

48 e cytoplasm of Escherichia coli, Lactococcus lactis and Haloferax volcanii.

49 This effect is weaker in L. lactis and Hfx.

50 as previously observed for the Kluyveromyces lactis and human telomerase RNA pseudoknots.

51 of PIC2 Additionally, assays in Lactococcus lactis and in reconstituted liposomes directly demonstra

52 ere synthesized with optimal codon use for L lactis and joined with a linker; a signal sequence was a

53 Start, composed by Lactococcus lactis subsp. lactis and L. lactis subsp. cremoris (R704); QLA - with

54 Microbiological (Lactococcus lactis and Lactobacillus acidophilus counts, and functio

55 were identified in Lactococcus lactis subsp. lactis and Lactococcus cremoris subsp.

56 were identified in Lactococcus lactis subsp. lactis and Lactococcus cremoris subsp. cremoris.

57 a monocytogenes, following Lc. lactis subsp. lactis and Leuconostoc mesenteroides subsp. cremoris (20

58 Certain genes from Lactococcus lactis and Pseudomonas aeruginosa, including the nfxB ge

59 carboxylic acid production by Kluyveromyces lactis and Saccharomyces cerevisiae during two different

60 ional structure of Gal80p from Kluyveromyces lactis and show that it is structurally homologous to gl

61 In Lactococcus lactis and Staphylococcus carnosus, the ilvE gene produc

62 ces cerevisiae were expressed in Lactococcus lactis and studied in inside-out membrane vesicles and i

63 es cerevisiae, the dairy yeast Kluyveromyces lactis and the human pathogen Candida albicans.

64 units of ATP synthase in yeast Kluyveromyces lactis and trypanosome Trypanosoma brucei.

65 rying from 48.3% (B. circulans) to 34.9% (K. lactis), and 19.5% (A. oryzae).

66 ies (Saccharomyces cerevisiae, Kluyveromyces lactis, and Debaryomyces hansenii) are remarkably hetero

67 idge, such as Lactococcus casei, Lactococcus lactis, and Enterococcus faecium.

68 illus casei genome, expressed in Lactococcus lactis, and functionally characterized.

69 m the bacteria Escherichia coli, Lactococcus lactis, and Streptomyces griseus.

70 Unlike the scenario in E. coli, L. lactis appears to be auxotrophic for biotin in that it l

71 CD3 with a clinical-grade self-containing L. lactis, appropriate for human application, secreting hum

72 ese findings show that certain strains of L. lactis are well adapted for growth on plants and possess

73 teria, Enterococcus faecalis and Lactococcus lactis, are gram positive.

74 ted with the intake of probiotic Lactococcus lactis as tolerogenic adjuvant (combined therapy).

75 lacebo group, n = 365) or B. animalis subsp. lactis at a dose of 10(9) colony-forming units/d (interv

76 s containing Bifidobacterium animalis subsp. lactis (B. lactis) HN019 was topically administered in t

77 e genomes of Bifidobacterium animalis subsp. lactis B420 and Bi-07.

78 ge 340, a 936-type Lactococcus lactis subsp. lactis bacteriophage.

79 yruvate metabolism of mutants of Lactococcus lactis, based on previously published experimental data.

80 ially be used in the future to tailor the L. lactis-based combination therapy for individual patients

81 ment of the immune changes induced by the L. lactis-based therapy revealed elevated frequencies of CD

82 philus LA-5, Bifidobacterium animalis subsp. lactis BB-12 and Propionibacterium jensenii 702.

83 ); QB - with Bifidobacterium animalis subsp. lactis (BB 12); and QC, co-culture with the three probio

84 hamnosus strain GG [LGG] and Bifidobacterium lactis Bb12 [Bb12]), mimicking gut commensals in breastf

85 nd probiotic, Bfidobacterium animalis subsp. lactis (Bb12) (final dose verified at 10(5) colony formi

86 of lactose hydrolysis by the immobilized K. lactis beta-galactosidase using genipin as a crosslinker

87 (v/v), the maximum GOS concentration with K. lactis beta-galactosidase was achieved in 1 and 5h at 40

88 sidases, and at 95% lactose depletion for K. lactis beta-galactosidase.

89 Lactococcus lactis beta-phosphoglucomutase (beta-PGM) catalyzes the

90 Activated Lactococcus lactis beta-phosphoglucomutase (betaPGM) catalyzes the c

91 smid, pKR223, from Lactococcus lactis subsp. lactis biovar diacetylactis KR2 encodes two distinct bac

92 The in vivo function of the two L. lactis birA genes was judged by their abilities to compl

93 he probiotic Bifidobacterium animalis subsp. lactis Bl-04 binds alpha-(1,6)-linked glucosides and gal

94 vatus was out-competed by B. animalis subsp. lactis Bl-04 in mixed cultures growing on raffinose, the

95 P expression was required for survival of L. lactis but not S. pyogenes.

96 sed for the class 1A enzyme from Lactococcus lactis by determining kinetic isotope effects (KIEs) on

97 h levels in ATL, indicating redundancy in L. lactis carbohydrate metabolism on plant tissues.

98 multidrug transporter LmrP from Lactococcus lactis catalyses drug efflux in a membrane potential and

99 By testing a panel of L. lactis cell wall mutants, we observed that Lc-Lys and Lc

100 Furthermore, such piliated L. lactis cells evoked a higher TNF-alpha response during m

101 icient in binding fluid-phase gp-340, and L. lactis cells expressing AspA were not agglutinated by gp

102 accordance with the growth rate, provides L. lactis cells the means to ensure optimal CW plasticity w

103 eptides mediated higher binding levels of L. lactis cells to surface immobilized gp340 than did S. in

104 lus paracasei CNCM I-2116 or Bifidobacterium lactis CNCM I-3446 had a treatment effect or altered all

105 AATT motif, first identified for Lactococcus lactis CodY, with up to five mismatches play an importan

106 ression of AspA protein on the surface of L. lactis conferred biofilm-forming ability.

107 expression of sof49 in M1 GAS or Lactococcus lactis conferred marked increases in HEp-2 cell invasion

108 xpression of the gene product in Lactococcus lactis conferred the ability to adhere to VK2 cells, to

109 ce of the non-adherent bacterium Lactococcus lactis confers adherence to scavenger receptor gp340, hu

110 when expressed on surrogate host Lactococcus lactis, confers binding to immobilized salivary agglutin

111 l level, associated with response to this B. lactis-containing fermented milk product, and therefore

112 associated, putative hydrolases, Lactococcus lactis CsiA, Tn925 Orf14, and pIP501 TraG, partially com

113 nsitive, Gram-positive bacterium Lactococcus lactis Delta lmrA Delta lmrCD lacking major endogenous m

114 t containing Bifidobacterium animalis subsp. lactis DN-173 010 strain.

115 emented with Bifidobacterium animalis subsp. lactis DN-173010 versus a placebo yogurt, followed by a

116 NA interacts with crystalline Dps phases, L. lactis DNA:Dps complexes appeared as non-crystalline agg

117 Similar to Lactobacillus lactis Dps, a metal-binding site is found at the N-termi

118 of the non-pathogenic bacterium Lactococcus lactis during a human whole blood killing assay in a dos

119 plant habitat-specific traits of Lactococcus lactis during growth in an Arabidopsis thaliana leaf tis

120 ntrolling the amount of Y. lipolytica and K. lactis during production offers potential to manipulate

121 RL2010 appendages in nonpiliated Lactococcus lactis enhanced adherence to human enterocytes through e

122 overexpression of the pilB gene alone in L. lactis enhanced resistance to phagocyte killing, increas

123 els inoculated with low concentrations of K. lactis exhibited blue cheese-related attributes, associa

124 s demonstrate that oral immunization with L. lactis expressing an Ag on the tip of the group A Strept

125 on the surface of S. aureus- or Lactococcus lactis-expressing FnBPB could be activated to the potent

126 vances in the development of the Lactococcus lactis expression system have opened the way for the hig

127 A heterologous Lactococcus lactis expression system was used to express SdrF and it

128 acidophilus, Bifidobacterium animalis subsp lactis, Faecalibacterium prausnitzii, Bacteroides vulgat

129 tudy show that the use of B. animalis subsp. lactis failed to prevent nosocomial infections in an acu

130 c tests in yeast and produced in Lactococcus lactis for further biochemical characterizations using p

131 I methylase, which is required to protect L. lactis from AbiR toxicity.

132 r) 13(-/-) BMDCs showed a weak response to L lactis G121 and were unresponsive to its RNA.

133 ecule expression, and T-cell activation on L lactis G121 challenge.

134 attern recognition receptors through which L lactis G121 confers allergy protection.

135 In mice L lactis G121 RNA signals through TLR13; however, the most

136 d by TLR8-specific inhibitors, mediated by L lactis G121 RNA, and synergistically enhanced by activat

137 We examined the ability of Lactococcus lactis G121 to prevent allergic inflammatory reactions.

138 In vivo allergy protection mediated by L lactis G121 was dependent on endosomal acidification in

139 L lactis G121-induced cytokine release and surface express

140 Bacterial RNA is the main driver of L lactis G121-mediated protection against experimentally i

141 The TH1-polarizing activity of L lactis G121-treated human DCs was blocked by TLR8-specif

142 L lactis G121-treated murine BMDCs and human moDCs release

143 n mice of biologically contained Lactococcus lactis genetically modified to secrete the whole proinsu

144 (RNP) complex formed between the Lactococcus lactis group II intron and its self-encoded LtrA protein

145 work, we have trapped the native Lactococcus lactis group II intron RNP complex in its precursor form

146 nce of specific plant-inducible genes for L. lactis growth in ATL, xylose metabolism was targeted for

147 hibitor binding to the Class 1A DHOD from L. lactis has now been studied in detail and is reported he

148 s via the gut through Lactococcus lactis (L. lactis) has been demonstrated to be a promising approach

149 , chimeric ACPs were constructed in which L. lactis helix II replaced helix II of E. coli AcpP and vi

150 oduced using Bifidobacterium animalis subsp. lactis HN019 in co-culture with Streptococcus thermophil

151 Topical use of B. lactis HN019 promotes a protective effect against alveol

152 g Bifidobacterium animalis subsp. lactis (B. lactis) HN019 was topically administered in the subgingi

153 ed a domesticated transposase, Kluyveromyces lactis hobo/Activator/Tam3 (hAT) transposase 1 (Kat1), o

154 ys against the indicator strains Lactococcus lactis HP and Bacillus subtilis 6633.

155 ved MIC values against liquid cultures of L. lactis HP.

156 L. lactis HR279 and JHK24 demonstrates two datasets with an

157 Lactococcus lactis HR279 and JHK24 strains expressing high or low le

158 the 3.0-A crystal structure of Kluyveromyces lactis Hsv2, which shares significant sequence homologie

159 c analyses, we identified genes unique to L. lactis I-1631 involved in oxygen respiration.

160 L. lactis I-1631 may represent a promising vehicle to deliv

161 L. lactis I-1631 possesses genes encoding enzymes that deto

162 s used in the FMP, we found that Lactococcus lactis I-1631 was sufficient to ameliorate colitis.

163 Inactivation of the sodA gene abolished L. lactis I-1631's beneficial effect in the T-bet(-/-) Rag2

164 on with the x-ray structure of Lactobacillus lactis IIA(Lac) reveals some substantial structural diff

165 h in ATL than the dairy-associated strain L. lactis IL1403.

166 ion of beta-galactosidase from Kluyveromyces lactis in Aerosol-OT water-in-isooctane microemulsions w

167 d to the ribosome of the yeast Kluyveromyces lactis in both the canonical and rotated states at overa

168 the cheese supplemented with Bifidobacterium lactis in its isolated form showed the highest proteolyt

169 analysis indicating beneficial effects of B. lactis in particular.

170 the role of Bifidobacterium animalis subsp. lactis in preventing nosocomial infections in the acute

171 Unlike in L. lactis, in E. coli, Ll.LtrB retrotransposed frequently i

172 le to therapy results with plasmid-driven L. lactis Initial blood glucose concentrations (<350 mg/dL)

173 ng: unlike S. cerevisiae and C. albicans, K. lactis integrates nutritional signals, by means of Rme1,

174 ing group II Ll.LtrB intron from Lactococcus lactis into L. lactis 23S rRNA.

175 Previous studies of the Lactococcus lactis intron Ll.LtrB indicated that in its native host,

176 nsporter LmrA from the bacterium Lactococcus lactis is a homolog of the human multidrug resistance P-

177 The engineered L. lactis is able to develop biofilms on different surfaces

178 and the enzyme from the yeast Kluyveromyces lactis is most widely used.

179 The aspartate pool in L. lactis is negatively regulated by c-di-AMP, and high asp

180 s-specific as Acm2 purified from Lactococcus lactis is not glycosylated.

181 actobacillus rhamnosus 1937, and Lactococcus lactis JBB 500 were enriched with magnesium ions using P

182 nduction of those genes corresponded with L. lactis KF147 nutrient consumption and production of meta

183 L. lactis KF147, a strain originally isolated from plants,

184 charomyces cerevisiae (Sc) and Kluyveromyces lactis (Kl).

185 autoantigens via the gut through Lactococcus lactis (L. lactis) has been demonstrated to be a promisi

186 y model of the NADH oxidase from Lactococcus lactis (L.lac-Nox2) was also generated using the crystal

187 positions in four other yeasts-Kluyveromyces lactis, Lachancea kluyveri, Lachancea waltii and Schizos

188 re model cheeses inoculated with Lactococcus lactis LD61.

189 tococcus lactis LDH2 < E. faecalis LDH1 < L. lactis LDH1 </= Streptococcus pyogenes LDH.

190 of S. pyogenes LDH, E. faecalis LDH1, and L. lactis LDH1 and LDH2 at pH 6.

191 : Enterococcus faecalis LDH2 </= Lactococcus lactis LDH2 < E. faecalis LDH1 < L. lactis LDH1 </= Stre

192 The Lactococcus lactis Ll.LtrB group II intron encodes a reverse transcr

193 The mobile Lactococcus lactis Ll.LtrB group II intron integrates into DNA targe

194 Here, we show that the Lactococcus lactis Ll.LtrB group II intron splices accurately and ef

195 viously showed that the group II Lactococcus lactis Ll.LtrB intron could retrotranspose into ectopic

196 y involved in retrohoming of the Lactococcus lactis Ll.LtrB intron.

197 elivery technology based on live Lactococcus lactis (LL) bacteria for controlled secretion of the T1D

198 situ by the food-grade bacterium Lactococcus lactis (LL-IL-27), and tested its ability to reduce coli

199 In L. lactis, LlPC is required for efficient milk acidificatio

200 uperfamily transporter LmrP from Lactococcus lactis mediates protonmotive-force dependent efflux of a

201 The chromosome of Lactococcus lactis MG 1363 contains a 60 kb conjugative element call

202 ps proteins (DpsA and DpsB) from Lactococcus lactis MG1363 reveal for the first time the presence of

203 he tip of pili external to the surface of L. lactis might constitute a successful vaccine strategy.

204 eport the crystal structure of Kluyveromyces lactis MIND and examine its partner interactions, to und

205 -L-Lys(3); moreover, they do not lyse the L. lactis mutant containing only the nonamidated D-Asp cros

206 In Kluyveromyces lactis mutants lacking telomerase, recombinational telom

207 Two candidate probiotics, Lactococcus lactis NCC 2287 and Bifidobacterium lactis NCC 2818, wer

208 In this EoE model, supplementation with L. lactis NCC 2287 significantly decreased esophageal and b

209 Supplementation with another probiotic, B. lactis NCC 2818, had no significant effect on esophageal

210 tococcus lactis NCC 2287 and Bifidobacterium lactis NCC 2818, were tested in a murine model of EoE el

211 ism were further modified by Bifidobacterium lactis NCC2818 supplementation, although composition of

212 AbiZ causes phage phi31-infected Lactococcus lactis NCK203 to lyse 15 min early, reducing the burst s

213 Genetically modified Lactococcus lactis, non-pathogenic bacteria expressing the FNIII(7-1

214 pressed in the heterologous host Lactococcus lactis NZ9000, and the benefits of the newly acquired pa

215 Yarrowia lipolytica and Kluyveromyces lactis occur as part of Stilton cheese microflora yet ar

216 is model, we demonstrate here that RTE in K. lactis occurs by amplification of a sequence originating

217 ound no benefit from supplementation with B. lactis or L. paracasei in the treatment of eczema, when

218 ly supplements containing L. paracasei or B. lactis or placebo for a 3-month period, while receiving

219 nal studies on the inhibition of Lactococcus lactis PC (LlPC) by c-di-AMP.

220 le synthetic circuits can direct Lactococcus lactis populations to form programmed spatial band-pass

221 Here we report that Lactococcus lactis possesses two different orthologues of birA (birA

222 Certain strains of Lactococcus lactis produce the broad-spectrum bacteriocin nisin, whi

223 Lactococcus lactis produces the lantibiotic nisin, which is widely u

224 terologous expression of SdrD in Lactococcus lactis promoted bacterial survival in human blood.

225 the intestinal bacterium B. animalis subsp. lactis provide insights into rapid genome evolution and

226 solution NMR structure of the Kluyveromyces lactis pseudoknot, presented here, reveals that it conta

227 Increasing the inoculum concentration of K. lactis resulted in decreased variation between replicate

228 -resolution cryo-EM reconstruction of the L. lactis ribosome fused to the intron-LtrA RNP of a splici

229 eport the crystal structure of Kluyveromyces lactis Rtr1, which reveals a new type of zinc finger pro

230 odule, and an endochitinase from Lactococcus lactis show that the nonprocessive enzymes have more fle

231 . mes. subsp. cremoris and Lc. lactis subsp. lactis showed stimulator effects (160%).

232 s in the Gram-positive bacterium Lactococcus lactis showed that heme exposure strongly induced expres

233 terologous expression of Pic2 in Lactococcus lactis significantly enhanced CuL transport into these c

234 0.27, 0.82), and this was significant for B. lactis (SMD: +0.46; 95% CI: 0.08, 0.85) but not for L. c

235 s and of a mutant of the yeast Kluyveromyces lactis specifically defective in the transport of UDP- N

236 ing plasmid pEW104 isolated from Lactococcus lactis ssp. cremoris W10.

237 In contrast to the parent L. lactis strain (lacks SpyCEP), which was avirulent when a

238 Mucosal immunization of mice with this L. lactis strain expressing pilus-linked MBP* results in pr

239 Wild-type L. lactis strain KF147 but not an xylA deletion mutant was

240 We used L. lactis strain to colonize material surfaces and produce

241 rast, a strong benefit for the engineered L. lactis strain was observed in acid stress survival.

242 However, Lactococcus latics subsp. lactis strain X and Lactobacillus casei strain B extract

243 We identified a L. lactis strain, able to attenuate esophageal eosinophilic

244 n plasmid pJW566 and can protect Lactococcus lactis strains against bacteriophage infections in milk

245 al evolution of several isogenic Lactococcus lactis strains demonstrated the existence of a tradeoff

246 lysis of two Bifidobacterium animalis subsp. lactis strains revealed evolution by internal deletion o

247 Mice were then infected with Lactococcus lactis strains that differed only in SpyCEP expression.

248 ly sequenced Bifidobacterium animalis subsp. lactis strains, BL-04 and DSM 10140, to hydrogen peroxid

249 ve H(2)O(2) resistance in B. animalis subsp. lactis strains.

250 MPP contained Bifidobacterium animalis subsp Lactis, Streptococcus thermophiles, Lactobacillus bulgar

251 indicator gene previously employed in our L. lactis studies.

252 s, Lactobacillus bulgaricus, and Lactococcus lactis subsp Lactis.

253 d by Lactococcus lactis subsp. lactis and L. lactis subsp. cremoris (R704); QLA - with Lactobacillus

254 uction of two starter strains of Lactococcus lactis subsp. cremoris (strains from the Culture Collect

255 was also inhibited by 50% CFS of Lactococcus lactis subsp. lactis and 25% CFS of Leuconostoc lactis.

256 with culture Start, composed by Lactococcus lactis subsp. lactis and L. lactis subsp. cremoris (R704

257 hyl-1-butanol were identified in Lactococcus lactis subsp. lactis and Lactococcus cremoris subsp.

258 hyl-1-butanol were identified in Lactococcus lactis subsp. lactis and Lactococcus cremoris subsp. cre

259 5%) by Listeria monocytogenes, following Lc. lactis subsp. lactis and Leuconostoc mesenteroides subsp

260 ructure of phage 340, a 936-type Lactococcus lactis subsp. lactis bacteriophage.

261 actococcal plasmid, pKR223, from Lactococcus lactis subsp. lactis biovar diacetylactis KR2 encodes tw

262 25% CFS of Leu. mes. subsp. cremoris and Lc. lactis subsp. lactis showed stimulator effects (160%).

263 Recombinant HPP from Lactococcus lactis subsp. lactis that was expressed in Escherichia c

264 ffects of 50% CFS of S. thermophilus and Lc. lactis subsp. lactis were more than 70% by Staphylococcu

265 riocin (lantibiotic) produced by Lactococcus lactis subsp. lactis.

266 human isolates and S. pseudoporcinus subsp. lactis subsp. nov. for the dairy isolates.

267 tis subsp. lactis and 25% CFS of Leuconostoc lactis. subsp. cremoris.

268 onuclease-independent pathway, and, as in L. lactis, such events have a more random integration patte

269 in human and the budding yeast Kluyveromyces lactis telomerase RNAs contain unusual triple-helical se

270 This indicates that K. lactis telomeres have preferred termination points withi

271 We further demonstrate that K. lactis telomeric fragments produce banded patterns with

272 se triples, the 3D shape of the human and K. lactis TER pseudoknots are remarkably similar.

273 The Kluyveromyces lactis ter1-16T strain contains mutant telomeres that ar

274 amily multidrug transporter from Lactococcus lactis that mediates the efflux of cationic amphiphilic

275 combinant HPP from Lactococcus lactis subsp. lactis that was expressed in Escherichia coli contained

276 However, in retrotransposition in L. lactis, the intron inserts predominantly into single-str

277 In the yeast Kluyveromyces lactis, the telomerase RNA (Ter1) template has 30 nucleo

278 such as the stn1-M1 mutant of Kluyveromyces lactis, the telomeres appear to be continuously unstable

279 ced into the commensal bacterium Lactococcus lactis, the truncated CBD is also produced, showing that

280 The use of Lactococcus lactis to deliver a chosen antigen to the mucosal surfac

281 s, and we transfer the system to Lactococcus lactis to establish its broad functionality in bacteria.

282 eterologous expression system in Lactococcus lactis to overcome possible staphylococcal adherence red

283 ation with a probiotic organism, Lactococcus lactis, to elicit HIV-specific immune responses in the m

284 Lactococcus lactis transformed with plasmids expressing SpsD and Sps

285 fect the Gram-positive bacterium Lactococcus lactis using receptor-binding proteins anchored to the h

286 f SfbA in the noninvasive strain Lactococcus lactis was sufficient to promote fibronectin binding and

287 In Kluyveromyces lactis, we have identified a novel allele of the STN1 ge

288 intenance of this equilibrium in Lactococcus lactis, we isolated mutants that are resistant to the PG

289 tans, Staphylococcus aureus, and Lactococcus lactis were examined for functional complementation of a

290 CFS of S. thermophilus and Lc. lactis subsp. lactis were more than 70% by Staphylococcus aureus compa

291 ate dehydrogenase A (DHODA) from Lactococcus lactis, were characterized by employing single-molecule

292 found that Orc1 from the yeast Kluyveromyces lactis, which diverged from S. cerevisiae before the dup

293 g the KlCYC1 gene of the yeast Kluyveromyces lactis, which includes a single promoter and two poly(A)

294 Nkp1 and Nkp2, from the yeast Kluyveromyces lactis, with nanoflow electrospray ionization mass spect

295 Models of Y. lipolytica and K. lactis, with Penicillium roqueforti, were analysed using

296 ome of Lactobacillus reuteri and Lactococcus lactis without selection at frequencies ranging between

297 strated that the AbiR operon was toxic in L. lactis without the presence of the LlaKR2I methylase, wh

298 and this was significant for Bifidobacterium lactis (WMD: 1.5 bowel movements/wk; 95% CI: 0.7, 2.3 bo

299 Lactococcus lactis YdbC is a representative of DUF2128.

300 Here, we characterize the Lactococcus lactis yybP-ykoY orphan riboswitch as a Mn(2+)-dependent